Biology
CRISPR-Cas12a Base Editing Rescues Splicing Defects in a Cellular Model of Cystic Fibrosis
By Ana Beatriz Souza, Daniel Kim
DOI: 10.52011/epip.2024.1806
Scientists used a precise gene-editing tool to correct a common genetic mutation that causes cystic fibrosis, testing it on cells taken from patients' airways. The treatment fixed the faulty gene in about two-thirds of cells and restored normal function of the protein that regulates salt and water balance in the lungs, offering hope for a future one-time therapy for this disease.
Souza, A. B., Kim, D. (2024). CRISPR-Cas12a Base Editing Rescues Splicing Defects in a Cellular Model of Cystic Fibrosis. Eleventh Press International Journal of Multidisciplinary Research, 4(2). https://doi.org/10.52011/epip.2024.1806